Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
[Type here] Case / Control Flow Diagram for BPH (Benign Prostatetic Hyperplasia) If you have questions regarding any of the information presented here, please contact either Sarah Stallings ([email protected]) or Josh Denny ([email protected]) 1. Population: Genotyped for eMERGE Male Age >= 40 2. Population Exclusions Prostate, Penile, Urethral, and Bladder Cancer (ICD9 or Tumor Registry or Prob List, ever) 3a. Case 3b. Control 2 or more of any ICD-9 for BPH Evidence of regular outpatient visits (3 or more in any 2 year period) -AND-AND[1 or more of any BPH Meds NO [BPH ICD-9s -OR-OR1 or more CPT codes for BPH related surgeries] BPH Meds -ORBPH-related surgery CPT codes] [Type here] Case / Control Algorithm for BPH (Benign Prostatetic Hyperplasia) If you have questions regarding any of the information presented here, please contact either Sarah Stallings ([email protected]) or Josh Denny ([email protected]) Population: Include: eMERGE genotyped Gender = Male Age ≥ 40 Exclude those with Prostate & Bladder Cancer using ICD-9, Tumor Registry (if available) and keywords: [ ICD-9: (1 or more of any on separate days): 233.4-Carcinoma in situ of prostate 233.7-Carcinoma in situ of bladder 233.9-Carcinoma in situ of other and unspecified urinary organs 185 - Malignant neoplasm of prostate 187 - Malignant neoplasm of penis and other male genital organs 187.1 - Malignant neoplasm of prepuce 187.2 - Malignant neoplasm of glans penis 187.3 - Malignant neoplasm of body of penis 187.4 - Malignant neoplasm of penis, part unspecified 187.5 - Malignant neoplasm of epididymis 187.6 - Malignant neoplasm of spermatic cord 187.7 - Malignant neoplasm of scrotum 187.8 - Malignant neoplasm of other specified sites of male genital organs 187.9 - Malignant neoplasm of male genital organ, site unspecified 188 - Malignant neoplasm of bladder 188.0 - Malignant neoplasm of trigone of urinary bladder 188.1 - Malignant neoplasm of dome of urinary bladder 188.2 - Malignant neoplasm of lateral wall of urinary bladder 188.3 - Malignant neoplasm of anterior wall of urinary bladder 188.4 - Malignant neoplasm of posterior wall of urinary bladder 188.5 - Malignant neoplasm of bladder neck 188.6 - Malignant neoplasm of ureteric orifice 188.7 - Malignant neoplasm of urachus 188.8 - Malignant neoplasm of other specified sites of bladder 188.9 - Malignant neoplasm of bladder, part unspecified 189.2 Malign Neopl Ureter 189.3 - Malignant neoplasm of urethra 189.4 Mal Neo Paraurethral Glands 189.8 Mal Neo Urinary Nec 189.9 Mal Neo Urinary Nos OR Tumor Registry: Primary site = any of the following: C619 C670 C671 Prostate gland Trigone of Bladder Dome of Bladder [Type here] C672 C673 C674 C675 C676 C677 C678 C679 Lateral Wall of Bladder Anterior Wall of Bladder Posterior Wall of Bladder Bladder Neck Uretic Orifice Urachus Overlapping Lesion of Bladder Bladder, NOS OR Keyword: (1 or more of any of the following in Problem List): note these phrases are specific to Vanderbilt –your site may use variations of these phrases / abbreviations. Please use prostate and bladder cancer related keywords appropriate to your site to improve the exclusion of cancer patients from the sets. 'prostate cancer' 'malignant tumor of prostate' 'bladder CA' 'bladder cancer' ] Case: Include: ICD-9 Codes for BPH: (2 or more each of one or more on separate days): 600, 600.0, 600.0*, 600.2, 600.2*, 600.9, 600.9* AND [ CPT code for BPH-related surgery (1 or more of any): 52450, 52601, 52630, 52648, 53850, 53852, OR BPH MEDICATIONS: (one or more mention found with any of the following included: (form, strength, amount, route, frequency, or source) – include generic and brand names in query. Use the RXCUI for ingredient type if that is available at your site): Generic Names terazosin terazosin HCL doxazosin mesylate doxazosin tamsulosin alfuzosin silodosin dutasteride finasteride Brand names Hytrin Cardura, Cardura XL Flomax, Jalyn* Uroxatral Rapaflo Avodart, Jalyn* Propecia, Proscar RxNorm code (RXCUI for the Ingredient Term Type) 37798 (236495 precise ingredient CUI) 49276 (39273 precise ingredient CUI) 77492 17300 720825 228790 25025 [Type here] prazosin * combination drug Minipress, Minipress XL 8629 ] Control: Include: 3 or more outpatient visits in any 2-year period for age ≥40 Exclude: [ ICD-9 Codes for BPH (1 or more of any): 600, 600.0, 600.0*, 600.2, 600.2*, 600.9, 600.9*, 600 OR CPT code for BPH-related surgery (1 or more of any): 52450, 52601, 52630, 52648, 53850, 53852 OR BPH MEDICATIONS: (one or more mention found with any of the following included: (form, strength, amount, route, frequency, or source) – include generic and brand names in query. Use the RXCUI for ingredient type if that is available at your site): Generic Names terazosin terazosin HCL doxazosin mesylate doxazosin tamsulosin alfuzosin silodosin dutasteride finasteride prazosin * combination drug ] Brand names Hytrin Cardura, Cardura XL Flomax, Jalyn* Uroxatral Rapaflo Avodart, Jalyn* Propecia, Proscar Minipress, Minipress XL RxNorm code (RXCUI for the Ingredient Term Type) 37798 (236495 precise ingredient CUI) 49276 (39273 precise ingredient CUI) 77492 17300 720825 228790 25025 8629